Interplay between Lignans and Gut Microbiota: Nutritional, Functional and Methodological Aspects

Lignans are non-flavonoid polyphenols present in a wide range of foods frequently consumed in the Western world, such as seeds, vegetables and fruits, and beverages such as coffee, tea and wine. In particular, the human gut microbiota (GM) can convert dietary lignans into biologically active compoun...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Molecules (Basel, Switzerland) Ročník 28; číslo 1; s. 343
Hlavní autori: Baldi, Simone, Tristán Asensi, Marta, Pallecchi, Marco, Sofi, Francesco, Bartolucci, Gianluca, Amedei, Amedeo
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Switzerland MDPI AG 01.01.2023
MDPI
Predmet:
Bioavailability
Cell growth
Cereals
Chromatography
Chronic diseases
Diet
DNA methylation
enterolignans
Estrogens
Gas Chromatography-Mass Spectrometry
Gastrointestinal Microbiome
GC-MS
Gut microbiota
Health aspects
HPLC
Humans
lignans
Lignans - chemistry
Mass spectrometry
Metabolism
Metabolites
Methods
Microbiota
Microbiota (Symbiotic organisms)
Physiological aspects
phytoestrogens
Plant-based foods
Polyphenols
Prevention
Review
Seeds
Small intestine
Vegetables - chemistry
Italy
Mediterranean Area
GC-MS
enterolignans
phytoestrogens
HPLC
gut microbiota
lignans
ISSN:1420-3049, 1420-3049
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Lignans are non-flavonoid polyphenols present in a wide range of foods frequently consumed in the Western world, such as seeds, vegetables and fruits, and beverages such as coffee, tea and wine. In particular, the human gut microbiota (GM) can convert dietary lignans into biologically active compounds, especially enterolignans (i.e., enterolactone and enterodiol), which play anti-inflammatory and anti-oxidant roles, act as estrogen receptor activators and modulate gene expression and/or enzyme activity. Interestingly, recent evidence documenting those dietary interventions involving foods enriched in lignans have shown beneficial and protective effects on various human pathologies, including colorectal and breast cancer and cardiovascular diseases. However, considering that more factors (e.g., diet, food transit time and intestinal redox state) can modulate the lignans bioactivation by GM, there are usually remarkable inter-individual differences in urine, fecal and blood concentrations of enterolignans; hence, precise and validated analytical methods, especially gas/liquid chromatography coupled to mass spectrometry, are needed for their accurate quantification. Therefore, this review aims to summarize the beneficial roles of enterolignans, their interaction with GM and the new methodological approaches developed for their evaluation in different biological samples, since they could be considered future promising nutraceuticals for the prevention of human chronic disorders.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
These authors contributed equally to this work.
ISSN:1420-3049
1420-3049
DOI:10.3390/molecules28010343